CorMedix Inc. to Participate at the 7th Annual Truist Securities Life Sciences Summit
BERKELEY HEIGHTS, N.J., April 28, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that CorMedix management will participate in investor meetings at the 7th Annual Truist Securities Life Sciences Summit taking place on May 4 – 5, 2021.
Shadow IT â€“ Why You Need to Eliminate It and How
IDEA Showcase Startup Pitch Event & Reception
Exhibit Hall Grand Opening Reception - Hall D
Time: 5:00-7:00 pm